Literature DB >> 11395202

Protective immunity against influenza A virus induced by immunization with DNA plasmid containing influenza M gene.

K Okuda1, A Ihata, S Watabe, E Okada, T Yamakawa, K Hamajima, J Yang, N Ishii, M Nakazawa, K Okuda1, K Ohnari, K Nakajima, K Q Xin.   

Abstract

DNA vaccination is characterized by its preferential induction of the cytotoxic T cell lymphocyte (CTL) response and is expected to be a useful means of protection against viral infection. We examined the protective effect of an expression plasmid (pME18S-M) containing M1 and M2 genes of influenza A/PR/8/34. We detected the CTL activity by introducing these plasmids into BALB/c mice by either the intramuscular or the intranasal route. The influenza-specific antibody response was also induced, although its neutralizing effect against influenza virus was not observed. From 70 to 80% protection was observed in the mice immunized with the pME18S-M plasmid followed by lethal infection with influenza viruses of the A/WSN/33 and A/PR/8/34 strains, whereas all mice without the plasmid vaccination failed to survive. This protective activity was significantly weakened when the CD8(+) cells of these immunized mice were eliminated by several injections of anti-CD8 antibody. The protective activity was also weakened when anti-CD4 antibody was injected in the early phase of DNA vaccination. These data suggest that the pME18S-M plasmid is useful as a DNA vaccine for overcoming highly mutational influenza viruses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11395202     DOI: 10.1016/s0264-410x(01)00078-0

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  35 in total

1.  The viral theory of schizophrenia revisited: abnormal placental gene expression and structural changes with lack of evidence for H1N1 viral presence in placentae of infected mice or brains of exposed offspring.

Authors:  S Hossein Fatemi; Timothy D Folsom; Robert J Rooney; Susumu Mori; Tess E Kornfield; Teri J Reutiman; Rachel E Kneeland; Stephanie B Liesch; Kegang Hua; John Hsu; Divyen H Patel
Journal:  Neuropharmacology       Date:  2011-01-26       Impact factor: 5.250

Review 2.  Development of universal influenza vaccines based on influenza virus M and NP genes.

Authors:  M Zheng; J Luo; Z Chen
Journal:  Infection       Date:  2013-11-01       Impact factor: 3.553

3.  DNA vaccination elicits protective immune responses against pandemic and classic swine influenza viruses in pigs.

Authors:  J Patrick Gorres; Kelly M Lager; Wing-Pui Kong; Michael Royals; John-Paul Todd; Amy L Vincent; Chih-Jen Wei; Crystal L Loving; Eraldo L Zanella; Bruce Janke; Marcus E Kehrli; Gary J Nabel; Srinivas S Rao
Journal:  Clin Vaccine Immunol       Date:  2011-09-14

4.  Increased level and longevity of protective immune responses induced by DNA vaccine expressing the HIV-1 Env glycoprotein when combined with IL-21 and IL-15 gene delivery.

Authors:  Elizabeth Bolesta; Aleksandra Kowalczyk; Andrzej Wierzbicki; Cheryl Eppolito; Yutaro Kaneko; Masafumi Takiguchi; Leonidas Stamatatos; Protul A Shrikant; Danuta Kozbor
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

5.  Intranasal adenovirus-vectored vaccine for induction of long-lasting humoral immunity-mediated broad protection against influenza in mice.

Authors:  Eun Hye Kim; Hae-Jung Park; Gye-Yeong Han; Man-Ki Song; Alexander Pereboev; Jeong S Hong; Jun Chang; Young-Ho Byun; Baik Lin Seong; Huan H Nguyen
Journal:  J Virol       Date:  2014-06-11       Impact factor: 5.103

6.  GDF15 Is an Inflammation-Induced Central Mediator of Tissue Tolerance.

Authors:  Harding H Luan; Andrew Wang; Brandon K Hilliard; Fernando Carvalho; Connor E Rosen; Amy M Ahasic; Erica L Herzog; Insoo Kang; Margaret A Pisani; Shuang Yu; Cuiling Zhang; Aaron M Ring; Lawrence H Young; Ruslan Medzhitov
Journal:  Cell       Date:  2019-08-08       Impact factor: 41.582

7.  A consecutive priming-boosting vaccination of mice with simian immunodeficiency virus (SIV) gag/pol DNA and recombinant vaccinia virus strain DIs elicits effective anti-SIV immunity.

Authors:  Kenji Someya; Ke-Qin Xin; Kazuhiro Matsuo; Kenji Okuda; Naoki Yamamoto; Mitsuo Honda
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

Review 8.  The prospects and challenges of universal vaccines for influenza.

Authors:  Kanta Subbarao; Yumiko Matsuoka
Journal:  Trends Microbiol       Date:  2013-05-17       Impact factor: 17.079

9.  Induction of long-term protective immune responses by influenza H5N1 virus-like particles.

Authors:  Sang-Moo Kang; Dae-Goon Yoo; Aleksandr S Lipatov; Jae-Min Song; C Todd Davis; Fu-Shi Quan; Li-Mei Chen; Ruben O Donis; Richard W Compans
Journal:  PLoS One       Date:  2009-03-02       Impact factor: 3.240

10.  Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1.

Authors:  Stephen Mark Tompkins; Zi-Shan Zhao; Chia-Yun Lo; Julia A Misplon; Teresa Liu; Zhiping Ye; Robert J Hogan; Zhengqi Wu; Kimberly A Benton; Terrence M Tumpey; Suzanne L Epstein
Journal:  Emerg Infect Dis       Date:  2007-03       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.